HomeProductsBioactive CompoundsTransporters & Ion ChannelsATPaseDexlansoprazole
Chemical structure of CAS 138530-94-6

Dexlansoprazole

In Stock•Starting at $9 for 50 mg•Purity ≥ 97%
CAS No.138530-94-6
MDL No.MFCD13196699
MFC16H14F3N3O2S
MW369.40
InChI KeyMJIHNNLFOKEZEW-RUZDIDTESA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
50 mg97%$9In Stock
100 mg97%$9In Stock
250 mg97%$12In Stock
1 g97%$25In Stock
5 g97%$90In Stock
25 g98%$346In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Dexlansoprazole is a sulfoxide belonging to the benzimidazole class.

CAS No.138530-94-6
Product NameDexlansoprazole

Biological Targets

ATP4A·ATP4B

Associated Conditions

Barrett's esophagus·gastroesophageal reflux disease·peptic esophagitis·Peptic ulcer·Esophagitis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

Xenobiotica; the fate of foreign compounds in biological systems • Vol. 36, Issue 1 • 2006
PMID: 16507515DOI: 10.1080/00498250500485065

Enantioselective disposition of lansoprazole and rabeprazole in human plasma.

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan • Vol. 126, Issue 6 • 2006
PMID: 16755125DOI: 10.1248/yakushi.126.395

Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner.

Drug metabolism and disposition: the biological fate of chemicals • Vol. 33, Issue 2 • 2005
PMID: 15537834DOI: 10.1124/dmd.104.001438

Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro.

Xenobiotica; the fate of foreign compounds in biological systems • Vol. 35, Issue 1 • 2005
PMID: 15788366DOI: 10.1080/00498250400026472

Documentation

Similar Products